Prestige Consumer Healthcare (PBH) Non Operating Income (2010 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Non Operating Income came in at -$20.7 million in Q4 2025, down 75.11% year-on-year from -$83.1 million in Q4 2024, and down 96.23% quarter-over-quarter from -$10.5 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Non Operating Income (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Non Operating Income history runs 16 years deep, the most recent figure standing at -$20.7 million for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 75.11% year-over-year to -$20.7 million in Q4 2025; TTM through Dec 2025 was -$55.7 million, a 5.13% decrease from a year earlier, with the FY2025 full-year figure at -$52.6 million, up 20.81% from the prior year.
  • Non Operating Income slipped to -$20.7 million in Q4 2025 per PBH's latest filing, from -$10.5 million in the prior quarter.
  • Across five years, Non Operating Income topped out at -$10.0 million in Q2 2025 and bottomed at -$30.6 million in Q1 2021.
  • The 5-year median for Non Operating Income is -$16.5 million (2022), against an average of -$16.5 million.
  • Across the five-year window, Non Operating Income soared 46.15% in 2022 and sank 75.11% in 2025, its largest moves.
  • Year by year, Non Operating Income stood at -$17.1 million in 2021, then decreased by 11.5% to -$19.1 million in 2022, then grew by 9.49% to -$17.3 million in 2023, then jumped by 31.58% to -$11.8 million in 2024, then sank by 75.11% to -$20.7 million in 2025.
  • Per Business Quant, the three latest PBH Non Operating Income figures stand at -$20.7 million (Q4 2025), -$10.5 million (Q3 2025), and -$10.0 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -7.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Prestige Consumer Healthcare 2.34 Bn 2.28 Bn 157.37 Mn -20.68 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -20.68 Mn
Sep 30, 2025 -10.54 Mn
Jun 30, 2025 -9.98 Mn
Mar 31, 2025 -14.47 Mn
Dec 31, 2024 -11.81 Mn
Sep 30, 2024 -12.68 Mn
Jun 30, 2024 -13.63 Mn
Mar 31, 2024 -14.83 Mn
Dec 31, 2023 -17.26 Mn
Sep 30, 2023 -17.84 Mn
Jun 30, 2023 -16.48 Mn
Mar 31, 2023 -18.53 Mn
Dec 31, 2022 -19.07 Mn
Sep 30, 2022 -17.79 Mn
Jun 30, 2022 -16.12 Mn
Mar 31, 2022 -16.46 Mn
Dec 31, 2021 -17.10 Mn
Sep 30, 2021 -18.93 Mn
Jun 30, 2021 -14.97 Mn
Mar 31, 2021 -30.56 Mn